Interessante Biotech-Aktie: VBI Vaccines (VBIV)

Homepage: http://www.vbivaccines.com

Management: http://www.vbivaccines.com/about/management-team/

About: http://www.vbivaccines.com/about/

Events/Presentation: http://www.vbivaccines.com/investors/events-presentations/

Technlogy: http://www.vbivaccines.com/technology/

Pipeline: http://www.vbivaccines.com/programs/

Investors: http://www.vbivaccines.com/about/

News: http://www.vbivaccines.com/wire/

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac™, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vacis approved for use in Israel and 14 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel..  

https://seekingalpha.com/news/...et-on-2nd-successful-sci-b-vac-study  

https://www.analystratings.com/articles/...-buy-at-canaccord-genuity/  

Offering vorgeschlagen, Umfang und Konditionen bislang noch unklar

https://www.vbivaccines.com/wire/proposed-offering-april-2020/

 

Corona getrieben

https://www.fool.com/investing/2020/06/26/...-skyrocketing-today.aspx

 

2 Impfstoffkandidaten

https://www.reuters.com/article/...tes-for-human-trials-idUSKBN25M1P9

 

zusätzliche Biomarkerdaten der Phase 1/2a Studie von VBI-1901 sollen auf der ESMO 2020 veröffentlicht werden  

https://seekingalpha.com/article/...moderna-in-covid-19-vaccine-front

 

https://finance.yahoo.com/news/...ZnuIcHaD2vqVy-2ynFxZ3mm_fZg_gCoPKEG
 

noch jemand dabei,wie ist hier die lage?  

• die Belegschaft wird um 30-35% reduziert
  
• 1-für-30 Reverse-Aktiensplit geplant
  
• CFO Christopher McNulty tritt zurück

https://www.vbivaccines.com/press-releases/...nd-reverse-stock-split/

 

glaube das wird die neue mullen. absolute abzocke das ding.  

Alles eine Frage der Sichtweise! Der Offering Preis liegt bei 1,65$, die Aktie notiert knapp 20% tiefer, was nicht ungewöhnlich ist. Solche Aktien tradet man am besten sobald das Offering bekannt gegeben wird und der Discount zum Offering Preis mindestens 30% beträgt. 1,65$*0,7 = 1,16$. Das Tagestief lag bei 1,08$. Alles eine Frage des Timings.